Myeloma is rare, accounting for 1% of all cancers and 15% of blood
cancers, but it is the second most common blood cancer after
non-Hodgkin’s lymphoma.
In Europe about 40,000 people were diagnosed with myeloma in 2015, and this number is predicted to increase to almost 46,000 by 2025.
Myeloma can affect adults of any age, but it is much more common in people aged over 65 years, and in men rather than women.
